ArticleRadiology case reports2026
Mild encephalitis/encephalopathy with a reversible splenial lesion (MERS): A case report and review of the literature.
Article in Radiology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) is a rare clinico-radiological syndrome characterized by transient encephalopathy associated with a reversible lesion in the splenium of the corpus callosum, most commonly occurring in the setting of infection or metabolic disturbance. We report the case of a 21-year-old male who presented with an acute generalized seizure following an influenza-like illness. Brain magnetic resonance imaging (MRI) demonstrated a well-defined ovoid lesion in the midline splenium of the corpus callosum, hyperintense on T2-weighted and FLAIR sequences, with marked diffusion restriction and corresponding low apparent diffusion coefficient (ADC) values, without contrast enhancement. Laboratory investigations, including serum studies and cerebrospinal fluid analysis, were within normal limits. The patient was managed with supportive care and antiepileptic therapy, with complete clinical recovery. Follow-up MRI performed after recovery demonstrated complete resolution of the splenial lesion, confirming its transient nature. This case highlights the importance of recognizing MERS in young patients presenting with post-infectious altered consciousness or new-onset seizures and underscores the central role of MRI in establishing the diagnosis and excluding other causes of splenial diffusion restriction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.